Stock Markets

Daily coverage of equity markets, sectors, and major indices.

In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.

Articles

30,178 total articles

Fastly Shares Surge After Citi Conference Spotlight

Fastly Shares Surge After Citi Conference Spotlight

Fastly shares jumped after management's presentation at the Citi 2026 Global TMT Conference in New York. The move follows a strong Q2 2026 earnings report that delivered record revenue and margin metrics, a raised full-year revenue outlook, and growing anticipation for the company's September Investor Day.

Coherent Shows Strong Tactical Recovery Setup Amid Mixed Fundamentals

Coherent Shows Strong Tactical Recovery Setup Amid Mixed Fundamentals

Coherent (COHR) registers the most promising tactical recovery pattern within the optical-networking cohort as momentum indicators reset and the daily trend tips higher. The trade requires confirmation above $318.03 for a cleaner entry; downside risk sits near $283.38. Valuation and negative free cash flow make the stock a speculative recovery cand…

BKV Shares Drop Again as Share Registration and Analyst Cuts Weigh

BKV Shares Drop Again as Share Registration and Analyst Cuts Weigh

BKV Corp fell 6.5% in pre-market trading to $25.01, extending a pullback from its 52-week high of $32.81. The decline reflects a near-term selling overhang after the company's Aug. 20 registration of roughly 5.3 million shares for existing holders, coupled with a series of analyst price-target cuts and a soft macro market tone. Natural gas volatili…

Palmer Square Capital Weighs Strategic Sale as CLO Operations Dominate AUM

Palmer Square Capital Weighs Strategic Sale as CLO Operations Dominate AUM

Palmer Square Capital Management, a $37 billion credit firm run by Chris and Angie Long, is reportedly exploring a sale of the business. The firm’s CLO platform represents roughly $27 billion of its assets under management, and bankers have been engaged to solicit and narrow bids. Palmer Square’s investment scope includes opportunistic and private …

Pyxis Oncology Shares Slip After Positive Phase 1 Data for MICVO

Pyxis Oncology Shares Slip After Positive Phase 1 Data for MICVO

Pyxis Oncology reported updated Phase 1 monotherapy results for Micvotabart Pelidotin (MICVO) in second-line and later recurrent/metastatic head and neck squamous cell carcinoma. The data showed a 36% confirmed objective response rate and a 94% disease control rate among 33 efficacy-evaluable patients at a 5.4 mg/kg IV every-three-weeks dose. Media…